TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 33 (3) , 108275
Abstract
No abstract availableKeywords
Funding Information
- California Institute for Regenerative Medicine
- Crohn's and Colitis Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 77 references indexed in Scilit:
- phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census DataPLOS ONE, 2013
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide seriesJoint Bone Spine, 2012
- Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US PopulationDigestive Diseases and Sciences, 2012
- Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell FunctionScience, 2012
- ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survivalLaboratory Investigation, 2012
- Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial CommunitiesApplied and Environmental Microbiology, 2009
- Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian PopulationGastroenterology Research and Practice, 2009
- IL-23 plays a key role inHelicobacter hepaticus–induced T cell–dependent colitisJournal of Experimental Medicine, 2006
- VEGAN, a package of R functions for community ecologyJournal of Vegetation Science, 2003